Analyst Carter Gould of Barclays maintained a Buy rating on AbbVie (ABBV – Research Report), retaining the price target of $212.00. Carter Gould has given his Buy rating due to a combination of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback
